Vanguard Asset Management »

Upstream Bio shares owned by Vanguard Asset Management

Quarter-by-quarter ownership of Upstream Bio (UPB) shares owned by Vanguard Asset Management from 13F filings

Historical chart of Vanguard Asset Management investment in Upstream Bio

Tip: Access up to 7 years of quarterly data

All positions including Upstream Bio held by Vanguard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Upstream Bio by Vanguard Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $83k 9.3k 9.00

More positions owned by Vanguard Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Astrazeneca Ord (AZN)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Johnson & Johnson (JNJ)

View all positions for Vanguard Asset Management

Top funds holding Upstream Bio

FMR
OrbiMed Advisors
BlackRock
Decheng Capital
Enavate Sciences GP
Vanguard Group
Vanguard Capital Management
Omega Fund Management
State Street Corporation
Y-Intercept
Federated Investors
Geode Capital Management
Millennium Management
Wellington Management Company
SEB Asset Management AB

View all funds holding Upstream Bio